Aldosterone Antagonists in Addition to Renin Angiotensin System Antagonists for Preventing the Progression of CKD: Editorial Summary of a Cochrane Review

Am J Kidney Dis. 2021 May;77(5):810-812. doi: 10.1053/j.ajkd.2020.11.019. Epub 2021 Jan 5.

Authors

Edmund Y M Chung¹, Giovanni F M Strippoli²

Affiliations

¹ Department of Medicine, Royal North Shore Hospital, Sydney, Australia.
² Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy; Cochrane Kidney and Transplant, Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, Australia; School of Public Health, University of Sydney, Sydney, Australia. Electronic address: gfmstrippoli@gmail.com.

PMID: 33418014
DOI: 10.1053/j.ajkd.2020.11.019

No abstract available

Publication types

Editorial
Comment

MeSH terms

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Humans
Mineralocorticoid Receptor Antagonists*
Renal Insufficiency, Chronic*
Renin-Angiotensin System

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Mineralocorticoid Receptor Antagonists